Author's reply: Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults.

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput › Academic › peer review

1 Citaat (Scopus)

24 Downloads (Pure)

Originele taal-2	English
Aantal pagina's	1
Tijdschrift	European Journal of Internal Medicine
Volume	72
Vroegere onlinedatum	2-jan.-2020
DOI's	https://doi.org/10.1016/j.ejim.2019.12.021
Status	Published - feb.-2020

Toegang tot document

@article{a2f71d967a62442e9ebaf19988550c3c,

title = "Author's reply: Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults. ",

keywords = "Clinical trial, Enrichment, Generalisability, Baloxavir, Influenza",

author = "{de Haas}, {Esther C} and Luijendijk, {Hendrika J}",

year = "2020",

month = feb,

doi = "10.1016/j.ejim.2019.12.021",

language = "English",

volume = "72",

journal = "European Journal of Internal Medicine",

issn = "0953-6205",

publisher = "ELSEVIER SCIENCE BV",

}

TY - JOUR

T1 - Author's reply: Baloxavir for influenza

T2 - Enrichment obscured lack of effect in North-American adults.

AU - de Haas, Esther C

AU - Luijendijk, Hendrika J

PY - 2020/2

Y1 - 2020/2

KW - Clinical trial

KW - Enrichment

KW - Generalisability

KW - Baloxavir

KW - Influenza

U2 - 10.1016/j.ejim.2019.12.021

DO - 10.1016/j.ejim.2019.12.021

M3 - Comment/Letter to the editor

C2 - 31902562

VL - 72

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

ER -